Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-11

Clinical Trial Update: The Use of Flecainide for Treatment of Atrial Fibrillation

View source ↗

Summary

A completed clinical trial evaluates the use of flecainide for the treatment of atrial fibrillation. The study is sponsored by Lund University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • flecainide (flecainide)

Snippet

Sponsor: Lund University | Conditions: Atrial Fibrillation | Status: COMPLETED